Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,8694196,Abfw2,Abdominal fat weight QTL 2,16.58,0.001,visceral adipose mass (VT:0010063),abdominal fat pad weight to body weight ratio (CMO:0000095),3,29682732,74682732,Rat,n/a,region,qtl 1000,12879853,Am5,Aortic mass QTL 5,,0.001,aorta mass (VT:0002845),aorta weight to aorta length to body weight ratio (CMO:0002722),3,14090411,48562146,Rat,n/a,region,qtl 1000,12879868,Am6,Aortic mass QTL 6,,0.001,aorta mass (VT:0002845),aorta weight to aorta length to body weight ratio (CMO:0002722),3,31103589,72989078,Rat,n/a,region,qtl 1000,738019,Anxrr10,Anxiety related response QTL 10,3.9,,exploratory behavior trait (VT:0010471),number of entries into a discrete space in an experimental apparatus (CMO:0000960),3,40422921,85422921,Rat,n/a,region,qtl 1000,1600376,Arunc5,Aerobic running capacity QTL 5,,0.21,exercise endurance trait (VT:0002332),maximum distance run on treadmill (CMO:0001406),3,78700444,123700444,Rat,n/a,region,qtl 1000,2313101,Bmd76,Bone mineral density QTL 76,3.6,0.0001,tibia mineral mass (VT:1000283),total volumetric bone mineral density (CMO:0001728),3,28136728,51687917,Rat,n/a,region,qtl 1000,2313093,Bmd77,Bone mineral density QTL 77,2.2,0.0001,tibia mineral mass (VT:1000283),cortical volumetric bone mineral density (CMO:0001730),3,28136728,51687917,Rat,n/a,region,qtl 1000,4889975,Bmd81,Bone mineral density QTL 81,4.3,,tibia mineral mass (VT:1000283),total volumetric bone mineral density (CMO:0001728),3,39773247,51687917,Rat,n/a,region,qtl 1000,631685,Bp118,Blood pressure QTL 118,3.2,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),3,24655225,69655225,Rat,n/a,region,qtl 1000,631647,Bp122,Blood pressure QTL 122,6.2,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),3,32130997,77130997,Rat,n/a,region,qtl 1000,731172,Bp151,Blood pressure QTL 151,,0.04,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),3,14090411,48562146,Rat,n/a,region,qtl 1000,731180,Bp152,Blood pressure QTL 152,,0.03,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),3,55245276,95176874,Rat,n/a,region,qtl 1000,731180,Bp152,Blood pressure QTL 152,,0.03,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),3,55245276,95176874,Rat,n/a,region,qtl 1000,731180,Bp152,Blood pressure QTL 152,,0.03,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),3,55245276,95176874,Rat,n/a,region,qtl 1000,1300169,Bp177,Blood pressure QTL 177,2.96,,arterial blood pressure trait (VT:2000000),blood pressure time series experimental set point of the baroreceptor response (CMO:0002593),3,33477354,62922975,Rat,n/a,region,qtl 1000,1358885,Bp251,Blood pressure QTL 251,3.8,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),3,10639528,127023997,Rat,n/a,region,qtl 1000,1358888,Bp264,Blood pressure QTL 264,4.43,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),3,10639528,127023997,Rat,n/a,region,qtl 1000,61356,Bp37,Blood pressure QTL 37,3,,blood pressure trait (VT:0000183),systolic blood pressure (CMO:0000004),3,32130997,77130997,Rat,n/a,region,qtl 1000,631568,Bp92,Blood pressure QTL 92,2.2,0.005,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),3,13126914,41510346,Rat,n/a,region,qtl 1000,70191,BpQTLcluster4,Blood pressure QTL cluster 4,3,,arterial blood pressure trait (VT:2000000),absolute change in systolic blood pressure (CMO:0000607),3,6000748,51687917,Rat,n/a,region,qtl 1000,70191,BpQTLcluster4,Blood pressure QTL cluster 4,3,,arterial blood pressure trait (VT:2000000),absolute change in mean arterial blood pressure (CMO:0000533),3,6000748,51687917,Rat,n/a,region,qtl 1000,2313049,Bss72,Bone structure and strength QTL 72,2.6,0.0001,tibia area (VT:1000281),tibia midshaft cross-sectional area (CMO:0001717),3,28136728,51687917,Rat,n/a,region,qtl 1000,2313079,Bss73,Bone structure and strength QTL 73,1.5,,tibia size trait (VT:0100001),tibia midshaft cross-sectional area (CMO:0001717),3,28136728,51687917,Rat,n/a,region,qtl 1000,2313076,Bss74,Bone structure and strength QTL 74,2,0.0001,tibia strength trait (VT:1000284),tibia total energy absorbed before break (CMO:0001736),3,28136728,51687917,Rat,n/a,region,qtl 1000,634317,Bw117,Body weight QTL 117,3.58,,abdominal fat pad mass (VT:1000711),abdominal fat pad weight to body weight ratio (CMO:0000095),3,40523593,54745780,Rat,n/a,region,qtl 1000,8694386,Bw159,Body weight QTL 159,4.52,0.001,body lean mass (VT:0010483),lean tissue morphological measurement (CMO:0002184),3,29682732,74682732,Rat,n/a,region,qtl 1000,11565451,Bw177,Body weight QTL 177,,0.002,body mass (VT:0001259),body weight (CMO:0000012),3,31103589,72989078,Rat,n/a,region,qtl 1000,12879849,Bw180,Body weight QTL 180,,0.037,body mass (VT:0001259),body weight (CMO:0000012),3,14090411,48562146,Rat,n/a,region,qtl 1000,12879848,Bw181,Body weght QTL 181,,0.015,body mass (VT:0001259),body weight (CMO:0000012),3,72672290,127023997,Rat,n/a,region,qtl 1000,1331777,Bw24,Body weight QTL 24,3.503,,body mass (VT:0001259),body weight (CMO:0000012),3,40523593,92654473,Rat,n/a,region,qtl 1000,1354589,Bw31,Body weight QTL 31,3.3,,body mass (VT:0001259),body weight (CMO:0000012),3,33477354,81136227,Rat,n/a,region,qtl 1000,1354604,Bw36,Body weight QTL 36,2.9,,body mass (VT:0001259),body weight (CMO:0000012),3,33477354,108914061,Rat,n/a,region,qtl 1000,1358293,Bw38,Body weight QTL 38,6,0.0000031,body mass (VT:0001259),body weight (CMO:0000012),3,56735995,101735995,Rat,n/a,region,qtl 1000,1582238,Bw68,Body weight QTL 68,3.2,0.0064,body mass (VT:0001259),body weight (CMO:0000012),3,54630948,119830094,Rat,n/a,region,qtl 1000,1582210,Bw71,Body weight QTL 71,3.3,0.0012,body mass (VT:0001259),body weight (CMO:0000012),3,66711607,119830094,Rat,n/a,region,qtl 1000,1582218,Bw74,Body weight QTL 74,3.9,0.0021,body mass (VT:0001259),body weight (CMO:0000012),3,54630948,119830094,Rat,n/a,region,qtl 1000,1582249,Bw77,Body weight QTL 77,3.2,0.0025,epididymal fat pad mass (VT:0010421),epididymal fat pad weight to body weight ratio (CMO:0000658),3,54630948,66711785,Rat,n/a,region,qtl 1000,631665,Bw8,Body weight QTL 8,5.5,,body mass (VT:0001259),body weight (CMO:0000012),3,51821836,124513579,Rat,n/a,region,qtl 1000,2301970,Bw81,Body weight QTL 81,5.19,,body mass (VT:0001259),body weight (CMO:0000012),3,43295930,163640485,Rat,n/a,region,qtl 1000,2302276,Bw82,Body weight QTL 82,4.32,,body mass (VT:0001259),body weight (CMO:0000012),3,40523593,64880586,Rat,n/a,region,qtl 1000,61419,Cia11,Collagen induced arthritis QTL 11,5.6,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),3,34394121,103141944,Rat,n/a,region,qtl 1000,70216,Cm14,Cardiac mass QTL 14,2.1,,heart mass (VT:0007028),heart wet weight (CMO:0000069),3,30846101,172879276,Rat,n/a,region,qtl 1000,631200,Cm25,Cardiac mass QTL 25,4.8,0.0001,heart left ventricle mass (VT:0007031),heart left ventricle wet weight (CMO:0000071),3,63049050,92654302,Rat,n/a,region,qtl 1000,1581503,Cm58,Cardiac mass QTL 58,2.7,0.05,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),3,45406058,127023997,Rat,n/a,region,qtl 1000,2301400,Cm68,Cardiac mass QTL 68,,0.001,heart mass (VT:0007028),heart wet weight to body weight ratio (CMO:0002408),3,31103589,72989078,Rat,n/a,region,qtl 1000,2301971,Cm71,Cardiac mass QTL 71,4.63,,heart left ventricle mass (VT:0007031),heart left ventricle weight (CMO:0000776),3,43295930,163640485,Rat,n/a,region,qtl 1000,631676,Cm8,Cardiac mass QTL 8,7.03,0.0001,aorta mass (VT:0002845),aorta weight (CMO:0000076),3,18023664,63023664,Rat,n/a,region,qtl 1000,12879850,Cm91,Cardiac mass QTL 91,,0.001,heart mass (VT:0007028),heart wet weight to body weight ratio (CMO:0002408),3,14090411,48562146,Rat,n/a,region,qtl 1000,12879851,Cm92,Cardiac mass QTL 92,,0.001,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),3,14090411,48562146,Rat,n/a,region,qtl 1000,12879852,Cm93,Cardiac mass QTL 93,,0.001,heart right ventricle mass (VT:0007033),heart right ventricle weight to body weight ratio (CMO:0000914),3,14090411,48562146,Rat,n/a,region,qtl 1000,12879866,Cm94,Cardiac mass QTL 94,,0.001,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),3,31103589,72989078,Rat,n/a,region,qtl 1000,12879867,Cm95,Cardiac mass QTL 95,,0.047,heart right ventricle mass (VT:0007033),heart right ventricle weight to body weight ratio (CMO:0000914),3,31103589,72989078,Rat,n/a,region,qtl 1000,1354590,Despr11,Despair related QTL 11,,0.000031,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),3,29908255,74908255,Rat,n/a,region,qtl 1000,61377,Edpm3,Estrogen-dependent pituitary mass QTL 3,7.05,0.038,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),3,54631046,93415673,Rat,n/a,region,qtl 1000,1559282,Emca5,Estrogen-induced mammary cancer QTL 5,3.9,,mammary gland integrity trait (VT:0010552),percentage of study population developing mammary tumors during a period of time (CMO:0000948),3,45406058,177699992,Rat,n/a,region,qtl 1000,1582239,Epfw1,Epididymal fat weight QTL 1,4.5,0.0006,epididymal fat pad mass (VT:0010421),epididymal fat pad weight to body weight ratio (CMO:0000658),3,54630948,119830094,Rat,n/a,region,qtl 1000,2292613,Ept16,Estrogen-induced pituitary tumorigenesis QTL 16,8.3,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),3,48562146,115249962,Rat,n/a,region,qtl 1000,1358186,Ept2,Estrogen-induced pituitary tumorigenesis QTL 2,8.3,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),3,48562146,115249962,Rat,n/a,region,qtl 1000,2292591,Esta4,Estrogen-induced thymic atrophy QTL 4,,,thymus mass (VT:0004954),thymus wet weight (CMO:0000855),3,48561928,155263151,Rat,n/a,region,qtl 1000,2302273,Gluco35,Glucose level QTL 35,5.3,0.001,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),3,83817637,119509260,Rat,n/a,region,qtl 1000,2303593,Gluco46,Glucose level QTL 46,3,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),3,29908255,74908255,Rat,n/a,region,qtl 1000,737818,Hcar12,Hepatocarcinoma resistance QTL 12,2.6,,liver integrity trait (VT:0010547),volume of individual liver tumorous lesion (CMO:0001078),3,30114912,123700444,Rat,n/a,region,qtl 1000,1358905,Hrtrt17,Heart rate QTL 17,5.9,0.000014,heart pumping trait (VT:2000009),heart rate (CMO:0000002),3,10094081,93415837,Rat,n/a,region,qtl 1000,1300178,Hrtrt4,Heart rate QTL 4,3.74,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),3,45406058,94467785,Rat,n/a,region,qtl 1000,1354597,Kidm13,Kidney mass QTL 13,2.9,,kidney mass (VT:0002707),right kidney wet weight (CMO:0000082),3,43295930,108914061,Rat,n/a,region,qtl 1000,1582221,Kidm30,Kidney mass QTL 30,3.5,0.0008,kidney mass (VT:0002707),both kidneys wet weight (CMO:0000085),3,66711607,119830094,Rat,n/a,region,qtl 1000,2301414,Kidm37,Kidney mass QTL 37,,0.001,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),3,72973445,127023997,Rat,n/a,region,qtl 1000,10401810,Kidm53,Kidney mass QTL 53,,,kidney mass (VT:0002707),both kidneys wet weight as percentage of body weight (CMO:0000140),3,2631421,48562146,Rat,n/a,region,qtl 1000,11565452,Kidm57,Kidney mass QTL 57,,0.001,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),3,31103589,72989078,Rat,n/a,region,qtl 1000,12879854,Kidm63,Kidney mass QTL 63,,0.001,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),3,14090411,48562146,Rat,n/a,region,qtl 1000,2298542,Neuinf11,Neuroinflammation QTL 11,3.9,,nervous system integrity trait (VT:0010566),"spinal cord complement component 1, q subcomponent, B chain mRNA level (CMO:0002126)",3,10119318,79772001,Rat,n/a,region,qtl 1000,2302055,Pia30,Pristane induced arthritis QTL 30,3.5,0.001,blood autoantibody amount (VT:0003725),serum immunoglobulin M-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002111),3,29321714,74321714,Rat,n/a,region,qtl 1000,8552950,Pigfal12,Plasma insulin-like growth factor 1 level QTL 12,7.3,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),3,29682732,74682732,Rat,n/a,region,qtl 1000,1581546,Pur13,Proteinuria QTL 13,2.93,0.0335,total urine protein amount (VT:0000032),urine protein excretion rate (CMO:0000759),3,81136227,154416635,Rat,n/a,region,qtl 1000,1300111,Rf12,Renal function QTL 12,3.78,,renal blood flow trait (VT:2000006),absolute change in renal blood flow rate (CMO:0001168),3,62922868,127023997,Rat,n/a,region,qtl 1000,1331795,Rf30,Renal function QTL 30,3.708,,urine potassium amount (VT:0010539),urine potassium level (CMO:0000128),3,40523593,92654473,Rat,n/a,region,qtl 1000,1581568,Rf53,Renal function QTL 53,,,total urine protein amount (VT:0000032),urine protein excretion rate to body weight ratio (CMO:0001099),3,58204463,170534769,Rat,n/a,region,qtl 1000,631832,Sach1,Saccharin preference QTL 1,2.7,0.02,consumption behavior trait (VT:0002069),calculated saccharin drink intake volume (CMO:0001600),3,28136728,45772990,Rat,n/a,region,qtl 1000,2290452,Scl56,Serum cholesterol level QTL 56,2.26,,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),3,1,95176874,Rat,n/a,region,qtl 1000,10450794,Scl69,Serum cholesterol level QTL 69,6.3,0.001,blood LDL cholesterol amount (VT:0000181),blood low density lipoprotein cholesterol level (CMO:0000053),3,21223803,66223803,Rat,n/a,region,qtl 1000,10450804,Scl70,Serum cholesterol level QTL 70,4.7,0.001,blood LDL cholesterol amount (VT:0000181),blood low density lipoprotein cholesterol level (CMO:0000053),3,21223803,66223803,Rat,n/a,region,qtl 1000,10450813,Scl74,Serum cholesterol level QTL 74,5.8,0.001,blood LDL cholesterol amount (VT:0000181),blood low density lipoprotein cholesterol level (CMO:0000053),3,39248391,52182792,Rat,n/a,region,qtl 1000,10450816,Scl75,Serum cholesterol level QTL 75,4.4,0.001,blood LDL cholesterol amount (VT:0000181),blood low density lipoprotein cholesterol level (CMO:0000053),3,39248391,52182792,Rat,n/a,region,qtl 1000,9590136,Scort3,Serum corticosterone level QTL 3,23.37,0.001,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),3,29682732,74682732,Rat,n/a,region,qtl 1000,1358362,Srcrt2,Stress Responsive Cort QTL 2,2.78,,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),3,39248391,140271184,Rat,n/a,region,qtl 1000,10450852,Stl33,Serum triglyceride level QTL 33,3.4,0.05,blood LDL triglyceride amount (VT:0010699),blood lipoprotein triglyceride level (CMO:0002685),3,39248391,52182792,Rat,n/a,region,qtl 1000,724523,Tsu1,Thymus enlargement suppressive QTL 1,3.84,,thymus mass (VT:0004954),thymus weight to body weight ratio (CMO:0000612),3,51822008,120917851,Rat,n/a,region,qtl 1000,9590286,Uminl1,Urine mineral level QTL 1,3.5,0.001,urine mineral amount (VT:0015086),urine electrolyte level (CMO:0000593),3,29682732,74682732,Rat,n/a,region,qtl 1000,8662816,Vetf4,Vascular elastic tissue fragility QTL 4,4,,renal artery integrity trait (VT:0010642),number of ruptures of the internal elastic lamina of the renal arteries (CMO:0002563),3,61241033,165369047,Rat,n/a,region,qtl